Oral Presentation
Advances in Neuroblastoma Research Congress 2016
Days
Sunday, 19th June
Monday, 20th June
Tuesday, 21st June
Wednesday, 22nd June
Thursday, 23rd June
Friday, 24th June
Search
Speakers
Can germline and somatic mutations (or rare variants) help us identify "ultra-high risk" neuroblastoma and predict patient outcomes?
(#69)
Sharon Diskin
1
Children's Hospital of Philadelphia, Philadelphia, PA, United States
Not required